Literature DB >> 32971385

Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.

Katrina T Roberto1, Adrian I Espiritu2, Marc Laurence L Fernandez3, Josephine C Gutierrez3.   

Abstract

BACKGROUND: Antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis is a distinct syndrome of early onset faciobrachial dystonic seizures (FBDS) and other focal seizures followed by neuropsychiatric symptoms. The electroclinical syndrome of this condition is yet to be fully understood. The main objective of this study was to determine the frequencies of electroencephalogram (EEG) findings in patients diagnosed with anti-LGI1 autoimmune encephalitis through a systematic review of published relevant articles.
METHODS: Major electronic healthcare databases were searched for relevant published articles until July 2020.
RESULTS: From 327 articles, 23 case reports and 14 case series were included in the review after satisfying the eligibility criteria. Data from a total of 151 cases of definite anti-LGI1 encephalitis were analyzed in this systematic review. Epileptiform discharges were the most frequent finding at 57.3%. Focal electroencephalographic abnormalities including slow wave (59.3%) and epileptiform activities (53.5%) most commonly arise from the temporal region. Faciobrachial dystonic seizures often have no ictal electroencephalographic correlate but would show electrodecremental events when seizure duration is prolonged.
CONCLUSION: Electroencephalogram abnormalities are seen in anti-LGI1 autoimmune encephalitis with epileptiform discharges as the most common finding followed by focal slowing. These findings were most frequently seen arising in the temporal region. Further studies using a standardized protocol focusing on electroencephalographic findings in anti-LGI1 encephalitis with clinical correlation to disease stage and treatment outcomes in terms of seizure control and memory and cognitive function are needed. Particular attention on ictal electrodecremental activity during FBDS should be done in studies with a larger sample size.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antileucine-rich glioma-inactivated 1; Autoimmune encephalitis; Electroencephalogram; Epilepsy; Faciobrachial dystonic seizures

Mesh:

Substances:

Year:  2020        PMID: 32971385     DOI: 10.1016/j.yebeh.2020.107462

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study.

Authors:  Rabia Gokcen Gozubatik-Celik; Zeynep Bastug Gul; Elif Bengisu Bilgin; Mina Uzulmez Yildiz; Onur Yenidunya; Handan Misirli; Havva Tugba Celik; Fatma Kurtulus; Aylin Yaman; Fusun Domac; Rahsan Karaci; Ozlem Cokar; Ayla Culha Oktar; Ufuk Emre Toprak; Nurettin Yavuz; Elif Dalgıc; Banu Ozen Barut; Pelin Dogan Ak; Cisil Irem Ozgenc; Nazlı Gamze Bulbul; Murat Mert Atmaca; F Munevver Gokyigit; Zahide Mail Gürkan; Nevin Pazarci; Reyhan Surmeli; Nilufer Kale; Zerrin Yildirim; Vildan Yayla; Necla Sozer; Murat Cabalar; Firuze Delen; Serap Ucler; Elif Unal; M Ali Sungur; Aysu Sen; Dilek Atakli; Aysun Soysal
Journal:  Neurol Sci       Date:  2022-02-24       Impact factor: 3.307

2.  Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.

Authors:  Yuou Teng; Ting Li; Zhizhong Yang; Mingwan Su; Jingnian Ni; Mingqing Wei; Jing Shi; Jinzhou Tian
Journal:  Front Neurol       Date:  2022-01-12       Impact factor: 4.003

3.  Autoimmune Encephalitis in the Philippines: A Scoping Review on the Treatment Gaps, Challenges, and Current State of Care.

Authors:  Gerald T Pagaling; Christian Wilson R Turalde; Roland Dominic G Jamora
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.